Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
Yimei Feng(Xinqiao Hospital), Peiyan Kong(Army Medical University), Zhongmin Zou(Army Medical University), Yun Zhang(Army Medical University), Lu Wang(Beijing Tsinghua Chang Gung Hospital), Xi Zhang(Army Medical University), Ting Chen(Nanchang University), Lu Zhao(Liaoning Provincial People's Hospital), Yuqing Liu(Sichuan Normal University), Han Yao(Army Medical University), Kaniel Cassady(Regeneron (United States)), Lei Gao(Zhejiang Chinese Medical University), Ping Wang(Guangzhou Medical University)
Cited by 4
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Ambient Temperature and the Risk of Preterm Birth in Guangzhou, China (2001–2011)
|Environmental Health Perspectives|2015|169
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Mito‐TEMPO Alleviates Renal Fibrosis by Reducing Inflammation, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress
|Oxidative Medicine and Cellular Longevity|2018|100